Skip navigation

Search results for the

Showing 526 to 540 of 2068 results

HCPC response to DHSC healthcare regulation consultation

As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.

Position statements

Find individual position statements from the HCPC

International applications

For applicants who trained outside the United Kingdom

#myhcpcstandards: Maintaining fitness to practise

In this webinar we will explore the requirement to the requirement to look after your own health and wellbeing, ensuring you are fit to practise.

Employer case study - The effects of well-supported CPD (Optima Health)

Karen Philpotts, Head of Clinical Standards (MSH and MH) at Optima Health, shares a case study on the impact of well-supported CPD on one practitioner and their team.

Reclassification of Gabapentin and Pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

HCPC gender, ethnicity and disability pay gaps report 2024

Annual reports on the gender and ethnicity pay gaps, with this year marking the first publication of the disability pay gap.

Education annual data set: 2018-19 academic year

Snapshot of outcomes related to the HCPC’s education function for the 2018-19 academic year

Supporting former registrants who worked as part of the COVID-19 recovery

For those who practised as part of the COVID-19 recovery, our returning to practice processes will take into account any impact this may have had on the wider healthcare workforce.